Letters

A new look for Yale Medicine

As it happens both of this issue’s feature stories are about cancer. Marc Wortman reports on a controversial theory that holds that certain stem cells underlie cancer and that identifying these cells can lead to new possibilities for treatment. Kara Nyberg reports on a partnership between the School of Medicine and Gilead Sciences in which the pharmaceutical company underwrites research at Yale that could lead to new targets for drugs to fight cancer. Having two articles on a related topic in this issue owes more to serendipity than our editorial prescience, but starting with our autumn issue, the features in Yale Medicine will all be linked by a theme in science or medicine. This focus will allow us to explore in depth advances in science and medicine not just at Yale but around the world.

This thematic approach is part of a new vision for the magazine as we embark on a redesign to give...

Read more...

Meeting alumni on the residency trail

One of the highlights of my residency interview season was meeting alumni of our school. These encounters were among the most pleasant on the interview trail because the conversations would frequently turn to the Yale system. Having represented my colleagues on the school-wide Educational Policy Committee during medical school, I had the special privilege of helping carry out the committee’s charge to interpret the...

Read more...

Writing and medicine

The Internal Medicine Writers’ Workshop was a big draw for me when I was interviewing for residency [“Writers’ Workshop...

Read more...

The complexities of EMRs

I enjoyed reading “Yale’s Epic Challenge” in the Winter 2013 Yale Medicine. As a former CMIO who trained in medical...

Read more...

Second opinion

Second opinion

A “second opinion” from cartoonist Sidney Harris.

Read more...



 
Download on the Apple App Store